A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Ovarian Cancer|Colon Cancer|Lung Cancer|Gastric Cancer|Solid Tumors
Interventions: DRUG: Veliparib|DRUG: Carboplatin|DRUG: Paclitaxel|DRUG: FOLFIRI
Sponsor: AbbVie